Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand offering superior stereoselectivity for asymmetric allylation and cost-effective pharmaceutical intermediate manufacturing.
Patent CN108864189A reveals a novel one-pot synthesis for sulfinamide chiral ligands, enabling cost-effective production of high-purity pharmaceutical intermediates via asymmetric Heck reactions.
Patent CN111217847B introduces efficient thiosilane ligands for aryl boronation, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Novel catalytic method for C2-phosphono indoles. High atom economy, mild conditions. Reliable supplier for pharmaceutical intermediates.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
Patent CN108794420B discloses a novel bisoxazoline ligand synthesis from cheap bisphenols, offering significant cost reduction and scalable production for asymmetric catalysis.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Patent CN102516300A discloses efficient phosphine ligands enabling superior enantioselectivity and simplified synthesis for cost-effective pharmaceutical intermediate manufacturing.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.
Patent CN111925356A discloses stable chiral ligands enabling high-yield nickel-catalyzed lactam synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel biaryl-based ligand enables high-yield palladium-catalyzed asymmetric allylic substitution with exceptional enantioselectivity and simplified synthesis.
Patent CN106588983B reveals novel ligands enabling low-loading Pd catalysis for acetone monoarylation, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114409714A reveals a novel Pd-catalyzed method for synthesizing high-purity 1,3-disubstituted planar chiral metallocenes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel two-step synthesis of axial chiral ligands from aryl halides offers cost-effective, high-enantioselectivity solutions for pharmaceutical manufacturing.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Advanced phosphine ligands with benzofuran structures for high-yield Suzuki-Miyaura reactions. Enhancing supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand synthesis enabling high-yield asymmetric difunctionalization for cost-effective API manufacturing.
Patent CN115155658B details a novel one-pot synthesis for VAPOL-based selenium-sulfur catalysts, offering cost-effective solutions for asymmetric organic manufacturing.
Patent CN107459533B discloses stable phosphine ligands enabling low-loading palladium catalysis. Discover cost-effective solutions for pharmaceutical intermediate manufacturing.